Priovant Starts Phase 3 Study of Brepocitinib in C...
Category : Clinical Trial Update 10 August 2026First Patients Enrolled in BEACON+ Study Priovant Therapeutics has started its phase 3 clinical s...
First Patients Enrolled in BEACON+ Study Priovant Therapeutics has started its phase 3 clinical s...
First Patient Trial Begins for Investigational Therapy Targeting mutCALR-Driven Blood Disorders D...
4Moving Biotech (4MB), a clinical-stage biotechnology company dedicated to developing first-in-class...
AusperBio Advances Its Second Clinical-Stage Hepatitis B Therapy AusperBio Therapeutics Inc. and...
New Two-Year Phase 3 Results Highlight Long-Term Benefits of Voyxact Otsuka Pharmaceutical Develo...